Wijnen PAHM, Bekers O, Drent M.
Development of cocaine-induced interstitial lung damage in two CYP2C and VKORC1 variant allele carriers. 
Mol Diagn Ther 2011; 15: 177-180.

Wijnen PAHM, Linssen CFM, Haenen GR, Bekers O, Drent M.
Variant VKORC1 and CYP2C9 alleles in patients using coumarin based anticoagulants associated with risk of diffuse alveolar haemorrhage.
Mol Diagn Ther 2010; 14: 23-30.

Wijnen PAHM, Bekers O, Drent M.
Relationship between drug-induced interstitial lung diseases and CYP polymorphisms.
Curr Opinion Pul Med 2010; 496-502.

Wijnen PAHM, Limantoro I, Drent M, Bekers O, Kuijpers PMJC, Koek GH.
Depressive effect of an antidepressant: therapeutic failure of venlafaxine in a case lacking CYP2D6 activity.
Ann Clin Biochem 2009; 46: 527-30.

Wijnen PAHM, Drent M, Nelemans P, et al.
Relationship of cytochrome P450 polymorphisms in pulmonary drug toxicity.
Drug Saf; 2008: 31: 1125-34.

Summary of the congres entitled: ‘Drug-induced, occupational and environmental related lung diseases.’
Utrecht, 30 september 2004, Karel V.

Drent M, Singh S, Gorgels A, Hansell D, et al.
Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine.
Am J Respir Crit Care Med 2003; 167: 958-961.

Drent M, Gorgels A, Bast A.
Cardiac failure associated with G6PD deficiency.
Circ Res 2003;93;75.

Drent M, Wessels S, Jacobs J, Thijssen H.
Association of diffuse alveolar haemorrhage with acquired vitamin K deficiency
Respiration 2000;67:697.

Drent M.
(Dex)fenfluramine-induced interstitial pneumonitis.
Eur J Intern Med 2000; 11: 290.

Wilschut F, Cobben N, Thunissen F, Lamers R, Wouters E, Drent M.
Recurrent respiratory distress associated with carbamazepine overdose.
Eur Respir J 1997; 10: 2163–2165.